Global Gaucher Disease (GD) Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4805570
- 88 Pages
- January 2022
- Pharmaceuticals
The United States Gaucher Disease (GD) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gaucher Disease (GD) Drugs market, reaching US$ million by the year 2028. As for the Europe Gaucher Disease (GD) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gaucher Disease (GD) Drugs players cover Sanofi, Shire, Actelion Pharma, and Pfizer (Protalix), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gaucher Disease (GD) Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Enzyme Replacement Therapy
Substrate Reduction Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Shire
Actelion Pharma
Pfizer (Protalix)
ISU ABXIS
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gaucher Disease (GD) Drugs Market Size 2017-2028
2.1.2 Gaucher Disease (GD) Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gaucher Disease (GD) Drugs Segment by Type
2.2.1 Enzyme Replacement Therapy
2.2.2 Substrate Reduction Therapy
2.3 Gaucher Disease (GD) Drugs Market Size by Type
2.3.1 Gaucher Disease (GD) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gaucher Disease (GD) Drugs Market Size Market Share by Type (2017-2022)
2.4 Gaucher Disease (GD) Drugs Segment by Application
2.4.1 Non-neuronopathic Gaucher Disease
2.4.2 Neuronopathic Gaucher Disease
2.5 Gaucher Disease (GD) Drugs Market Size by Application
2.5.1 Gaucher Disease (GD) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gaucher Disease (GD) Drugs Market Size Market Share by Application (2017-2022)
3 Gaucher Disease (GD) Drugs Market Size by Player
3.1 Gaucher Disease (GD) Drugs Market Size Market Share by Players
3.1.1 Global Gaucher Disease (GD) Drugs Revenue by Players (2020-2022)
3.1.2 Global Gaucher Disease (GD) Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Gaucher Disease (GD) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gaucher Disease (GD) Drugs by Regions
4.1 Gaucher Disease (GD) Drugs Market Size by Regions (2017-2022)
4.2 Americas Gaucher Disease (GD) Drugs Market Size Growth (2017-2022)
4.3 APAC Gaucher Disease (GD) Drugs Market Size Growth (2017-2022)
4.4 Europe Gaucher Disease (GD) Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Gaucher Disease (GD) Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gaucher Disease (GD) Drugs Market Size by Country (2017-2022)
5.2 Americas Gaucher Disease (GD) Drugs Market Size by Type (2017-2022)
5.3 Americas Gaucher Disease (GD) Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gaucher Disease (GD) Drugs Market Size by Region (2017-2022)
6.2 APAC Gaucher Disease (GD) Drugs Market Size by Type (2017-2022)
6.3 APAC Gaucher Disease (GD) Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gaucher Disease (GD) Drugs by Country (2017-2022)
7.2 Europe Gaucher Disease (GD) Drugs Market Size by Type (2017-2022)
7.3 Europe Gaucher Disease (GD) Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gaucher Disease (GD) Drugs by Region (2017-2022)
8.2 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gaucher Disease (GD) Drugs Market Forecast
10.1 Global Gaucher Disease (GD) Drugs Forecast by Regions (2023-2028)
10.1.1 Global Gaucher Disease (GD) Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Gaucher Disease (GD) Drugs Forecast
10.1.3 APAC Gaucher Disease (GD) Drugs Forecast
10.1.4 Europe Gaucher Disease (GD) Drugs Forecast
10.1.5 Middle East & Africa Gaucher Disease (GD) Drugs Forecast
10.2 Americas Gaucher Disease (GD) Drugs Forecast by Country (2023-2028)
10.2.1 United States Gaucher Disease (GD) Drugs Market Forecast
10.2.2 Canada Gaucher Disease (GD) Drugs Market Forecast
10.2.3 Mexico Gaucher Disease (GD) Drugs Market Forecast
10.2.4 Brazil Gaucher Disease (GD) Drugs Market Forecast
10.3 APAC Gaucher Disease (GD) Drugs Forecast by Region (2023-2028)
10.3.1 China Gaucher Disease (GD) Drugs Market Forecast
10.3.2 Japan Gaucher Disease (GD) Drugs Market Forecast
10.3.3 Korea Gaucher Disease (GD) Drugs Market Forecast
10.3.4 Southeast Asia Gaucher Disease (GD) Drugs Market Forecast
10.3.5 India Gaucher Disease (GD) Drugs Market Forecast
10.3.6 Australia Gaucher Disease (GD) Drugs Market Forecast
10.4 Europe Gaucher Disease (GD) Drugs Forecast by Country (2023-2028)
10.4.1 Germany Gaucher Disease (GD) Drugs Market Forecast
10.4.2 France Gaucher Disease (GD) Drugs Market Forecast
10.4.3 UK Gaucher Disease (GD) Drugs Market Forecast
10.4.4 Italy Gaucher Disease (GD) Drugs Market Forecast
10.4.5 Russia Gaucher Disease (GD) Drugs Market Forecast
10.5 Middle East & Africa Gaucher Disease (GD) Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Gaucher Disease (GD) Drugs Market Forecast
10.5.2 South Africa Gaucher Disease (GD) Drugs Market Forecast
10.5.3 Israel Gaucher Disease (GD) Drugs Market Forecast
10.5.4 Turkey Gaucher Disease (GD) Drugs Market Forecast
10.5.5 GCC Countries Gaucher Disease (GD) Drugs Market Forecast
10.6 Global Gaucher Disease (GD) Drugs Forecast by Type (2023-2028)
10.7 Global Gaucher Disease (GD) Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Gaucher Disease (GD) Drugs Product Offered
11.1.3 Sanofi Gaucher Disease (GD) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Shire
11.2.1 Shire Company Information
11.2.2 Shire Gaucher Disease (GD) Drugs Product Offered
11.2.3 Shire Gaucher Disease (GD) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Shire Main Business Overview
11.2.5 Shire Latest Developments
11.3 Actelion Pharma
11.3.1 Actelion Pharma Company Information
11.3.2 Actelion Pharma Gaucher Disease (GD) Drugs Product Offered
11.3.3 Actelion Pharma Gaucher Disease (GD) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Actelion Pharma Main Business Overview
11.3.5 Actelion Pharma Latest Developments
11.4 Pfizer (Protalix)
11.4.1 Pfizer (Protalix) Company Information
11.4.2 Pfizer (Protalix) Gaucher Disease (GD) Drugs Product Offered
11.4.3 Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer (Protalix) Main Business Overview
11.4.5 Pfizer (Protalix) Latest Developments
11.5 ISU ABXIS
11.5.1 ISU ABXIS Company Information
11.5.2 ISU ABXIS Gaucher Disease (GD) Drugs Product Offered
11.5.3 ISU ABXIS Gaucher Disease (GD) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 ISU ABXIS Main Business Overview
11.5.5 ISU ABXIS Latest Developments
12 Research Findings and Conclusion
Table 1. Gaucher Disease (GD) Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Enzyme Replacement Therapy
Table 3. Major Players of Substrate Reduction Therapy
Table 4. Gaucher Disease (GD) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Gaucher Disease (GD) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Gaucher Disease (GD) Drugs Market Size Market Share by Type (2017-2022)
Table 7. Gaucher Disease (GD) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Gaucher Disease (GD) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Gaucher Disease (GD) Drugs Market Size Market Share by Application (2017-2022)
Table 10. Global Gaucher Disease (GD) Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Gaucher Disease (GD) Drugs Revenue Market Share by Player (2020-2022)
Table 12. Gaucher Disease (GD) Drugs Key Players Head office and Products Offered
Table 13. Gaucher Disease (GD) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gaucher Disease (GD) Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Gaucher Disease (GD) Drugs Market Size Market Share by Regions (2017-2022)
Table 18. Americas Gaucher Disease (GD) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Gaucher Disease (GD) Drugs Market Size Market Share by Country (2017-2022)
Table 20. Americas Gaucher Disease (GD) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Gaucher Disease (GD) Drugs Market Size Market Share by Type (2017-2022)
Table 22. Americas Gaucher Disease (GD) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Gaucher Disease (GD) Drugs Market Size Market Share by Application (2017-2022)
Table 24. APAC Gaucher Disease (GD) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Gaucher Disease (GD) Drugs Market Size Market Share by Region (2017-2022)
Table 26. APAC Gaucher Disease (GD) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Gaucher Disease (GD) Drugs Market Size Market Share by Type (2017-2022)
Table 28. APAC Gaucher Disease (GD) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Gaucher Disease (GD) Drugs Market Size Market Share by Application (2017-2022)
Table 30. Europe Gaucher Disease (GD) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Gaucher Disease (GD) Drugs Market Size Market Share by Country (2017-2022)
Table 32. Europe Gaucher Disease (GD) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Gaucher Disease (GD) Drugs Market Size Market Share by Type (2017-2022)
Table 34. Europe Gaucher Disease (GD) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Gaucher Disease (GD) Drugs Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Gaucher Disease (GD) Drugs Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gaucher Disease (GD) Drugs Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gaucher Disease (GD) Drugs Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Gaucher Disease (GD) Drugs
Table 43. Key Market Challenges & Risks of Gaucher Disease (GD) Drugs
Table 44. Key Industry Trends of Gaucher Disease (GD) Drugs
Table 45. Global Gaucher Disease (GD) Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Gaucher Disease (GD) Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Gaucher Disease (GD) Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Gaucher Disease (GD) Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Gaucher Disease (GD) Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Gaucher Disease (GD) Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 51. Sanofi Details, Company Type, Gaucher Disease (GD) Drugs Area Served and Its Competitors
Table 52. Sanofi Gaucher Disease (GD) Drugs Product Offered
Table 53. Sanofi Gaucher Disease (GD) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Shire Details, Company Type, Gaucher Disease (GD) Drugs Area Served and Its Competitors
Table 57. Shire Gaucher Disease (GD) Drugs Product Offered
Table 58. Shire Main Business
Table 59. Shire Gaucher Disease (GD) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Shire Latest Developments
Table 61. Actelion Pharma Details, Company Type, Gaucher Disease (GD) Drugs Area Served and Its Competitors
Table 62. Actelion Pharma Gaucher Disease (GD) Drugs Product Offered
Table 63. Actelion Pharma Main Business
Table 64. Actelion Pharma Gaucher Disease (GD) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Actelion Pharma Latest Developments
Table 66. Pfizer (Protalix) Details, Company Type, Gaucher Disease (GD) Drugs Area Served and Its Competitors
Table 67. Pfizer (Protalix) Gaucher Disease (GD) Drugs Product Offered
Table 68. Pfizer (Protalix) Main Business
Table 69. Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Pfizer (Protalix) Latest Developments
Table 71. ISU ABXIS Details, Company Type, Gaucher Disease (GD) Drugs Area Served and Its Competitors
Table 72. ISU ABXIS Gaucher Disease (GD) Drugs Product Offered
Table 73. ISU ABXIS Main Business
Table 74. ISU ABXIS Gaucher Disease (GD) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. ISU ABXIS Latest Developments
List of Figures
Figure 1. Gaucher Disease (GD) Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gaucher Disease (GD) Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gaucher Disease (GD) Drugs Market Size Market Share by Type in 2021
Figure 7. Gaucher Disease (GD) Drugs in Non-neuronopathic Gaucher Disease
Figure 8. Global Gaucher Disease (GD) Drugs Market: Non-neuronopathic Gaucher Disease (2017-2022) & ($ Millions)
Figure 9. Gaucher Disease (GD) Drugs in Neuronopathic Gaucher Disease
Figure 10. Global Gaucher Disease (GD) Drugs Market: Neuronopathic Gaucher Disease (2017-2022) & ($ Millions)
Figure 11. Global Gaucher Disease (GD) Drugs Market Size Market Share by Application in 2021
Figure 12. Global Gaucher Disease (GD) Drugs Revenue Market Share by Player in 2021
Figure 13. Global Gaucher Disease (GD) Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Gaucher Disease (GD) Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Gaucher Disease (GD) Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Gaucher Disease (GD) Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Gaucher Disease (GD) Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Gaucher Disease (GD) Drugs Value Market Share by Country in 2021
Figure 19. Americas Gaucher Disease (GD) Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Gaucher Disease (GD) Drugs Market Size Market Share by Application in 2021
Figure 21. United States Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Gaucher Disease (GD) Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Gaucher Disease (GD) Drugs Market Size Market Share by Application in 2021
Figure 27. China Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Gaucher Disease (GD) Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Gaucher Disease (GD) Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Gaucher Disease (GD) Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Gaucher Disease (GD) Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Gaucher Disease (GD) Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Gaucher Disease (GD) Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Gaucher Disease (GD) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Gaucher Disease (GD) Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
